Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676)

Bibliography

• McLean KJ, Hans M, Munro AW. Cholesterol, an essential molecule: diverse roles involving cytochrome P450 enzymes. Biochem Soc Trans 2012;40:587-93
   PubMed Web of Science ®Google Scholar
• Heike K, Dieter L, Frank J, et al. CYP46A1 variants influence Alzheimer’s disease risk and brain cholesterol metabolism. Eur Psychiatry 2009;24:183-90
   PubMed Web of Science ®Google Scholar
• Bjoerkhem I, Loevgren-Sandblom A, Leoni V, et al. Oxysterols and Parkinson’s disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease. Neurosci Lett 2013;555:102-5
   PubMed Web of Science ®Google Scholar
• Koelsch H, Luetjohann D, Ludwig M, et al. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer’s disease. Mol Psychiatry 2002;7:899-902
   PubMed Web of Science ®Google Scholar
• Li L, Yin Z, Liu J, et al. CYP46A1 T/C polymorphism associated with the APOEepsilon4 allele increases the risk of Alzheimer’s disease. J Neurol 2013;260:1701-8
   PubMed Web of Science ®Google Scholar
• Schonknecht P, Lutjohann D, Pantel J, et al. 24S-hydroxycholesterol is increased in patients with Alzheimer’s disease compared to healthy controls. Neurosci Lett 2002;324:83-5
   PubMed Web of Science ®Google Scholar
• Leoni V, Shafaati M, Salomon A, et al. Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment? Neurosci Lett 2006;397:83-7
   PubMed Web of Science ®Google Scholar
• Leoni V, Solomon A, Loevgren-Sandblom A, et al. Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health. J Alzheimers Dis 2013;36:739-47
   PubMed Web of Science ®Google Scholar
• Papassotiropoulos A, Lutjohann D, Bagli M, et al. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res 2002;36:27-32
   PubMed Web of Science ®Google Scholar
• Zhao S, Liao W, Xu N, et al. Polar metabolite of cholesterol induces rat cognitive dysfunctions. Neuroscience 2009;164:398-403
   PubMed Web of Science ®Google Scholar
• Hudry E, Van Dam D, Kulik W, et al. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer’s disease. Mol Ther 2010;18:44-53
   PubMed Web of Science ®Google Scholar
• Paul SM, Doherty JJ, Robichaud AJ, et al. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors. J Neurosci 2013;33:17290-300
   PubMed Web of Science ®Google Scholar
• Mast N, Li Y, Linger M, et al. Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice. J Biol Chem 2014;289:3529-38
   PubMed Web of Science ®Google Scholar
• White M A, Mast N, Bjorkhem I, et al. Use of complementary cation and anion heavy-atom salt derivatives to solve the structure of cytochrome P450 46A1. Acta Crystallogr D Biol Crystallogr 2008;64:487-95
   PubMedGoogle Scholar
• Mast N, White M A, Bjorkhem I, et al. Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain. Proc Natl Acad Sci USA 2008;105:9546-51
   PubMed Web of Science ®Google Scholar
• Mast N, Charvet C, Pikuleva I A, et al. Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain. J Biol Chem 2010;285:31783-95
   PubMed Web of Science ®Google Scholar
• Shafaati M, Mast N, Beck O, et al. The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo. J Lipid Res 2010;51:318-23
   PubMed Web of Science ®Google Scholar
• Takeda Pharmaceutical Co. Ltd. Heterocyclic compound. WO10110400; 2010
   Google Scholar
• Takeda Pharmaceutical Co. Ltd. Heterocyclic compounds. WO13054822; 2013
   Google Scholar
• Takeda Pharmaceutical Co. Ltd. Heterocyclic compound. WO14061676; 2014
   Google Scholar
• Takeda Pharmaceutical Co. Ltd. Heterocyclic compound. WO14092100; 2014
   Google Scholar
• Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 2012;13:93-110
   PubMed Web of Science ®Google Scholar
• Puzzo D, Lee L, Palmeri A, et al. Behavioral assays with mouse models of Alzheimer’s disease: practical considerations and guidelines. Biochem Pharmacol 2014;88:450-67
   PubMed Web of Science ®Google Scholar
• Jeong S, Nguyen PD, Desta Z. Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A. Antimicrob Agents Chemother 2009;53:541-51
   PubMed Web of Science ®Google Scholar
• Theuretzbacher U, Ihle F, Derendorf H. Pharmacokinetic/pharmacodynamic profile of voriconazole. Clin Pharmacokinet 2006;45:649-63
   PubMed Web of Science ®Google Scholar
• Kotti TJ, Ramirez DM, Pfeiffer BE, et al. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc Natl Acad Sci USA 2006;103:3869-74
   PubMed Web of Science ®Google Scholar
• Russell DW, Halford RW, Ramirez DM, et al. Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu Rev Biochem 2009;78:1017-40
   PubMed Web of Science ®Google Scholar
• Muijsers RB, Goa KL, Scott LJ, et al. Voriconazole: in the treatment of invasive aspergillosis. Drugs 2002;62:2655-64
   PubMed Web of Science ®Google Scholar
• Fourgeux C, Martine L, Acar N, et al. In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina. Biochem Biophy Res Commun 2014;446:775-81
   PubMed Web of Science ®Google Scholar
• Fourgeux C, Bron A, Acar N, et al. 24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma. Chem Phys Lipids 2011;164:496-9
   PubMed Web of Science ®Google Scholar
• Takeda Pharmaceutical Co. Ltd. Web Site 2014. Available from: http://www.takeda.com/research/files/pipeline_20141030_en.pdf [Last accessed 10 November 2014]
   Google Scholar